T-Therapeutics Ltd

📍 Cambridge, United Kingdom🗓 Founded 2022👥 40 employees💰 Last funded Nov 2022
Biotechnology Research🌐 t-therapeutics.com
Website LinkedIn
T-Therapeutics is a venture-backed company on a mission to unlock the power of T cells to treat chronic and infectious diseases. Based on technology from Professor Allan Bradley’s laboratory in Cambridge University’s Department of Medicine, T-Therapeutics has secured significant investment from a blue-chip syndicate of investors to support its drug discovery efforts and prepare candidates for clinical development. T-Therapeutics was founded in 2022, and we are at the very beginning of our journey to develop transformative T cell derived medicines. To realise our ambition, we are currently building facilities, recruiting staff, and establishing our research operations.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2022
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in T-Therapeutics Ltd?
T-Therapeutics Ltd has 1 investors on record on gritt.io, including 1 early-stage backers.
When did T-Therapeutics Ltd last raise funding?
The most recent investment in T-Therapeutics Ltd recorded on gritt.io was in November 2022.
When was T-Therapeutics Ltd founded?
T-Therapeutics Ltd was founded in 2022.
What industry is T-Therapeutics Ltd in?
T-Therapeutics Ltd operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is T-Therapeutics Ltd based?
T-Therapeutics Ltd is headquartered in Cambridge, United Kingdom.